Developing Robust Bioinformatic Pipelines and Regulatory Requirements

Program Committee Moderator(s)

• 

  Heather Blankenship, PhD, HCLD

  Genomics Technical Director
  Michigan Department of Health and Human Services
  Lansing, Michigan, United States

Co-Moderator (Early Career)(s)

• 

  Wesley Goar, PhD (he/him/his)

  Manager of Genomics Systems and Data Integration
  Nationwide Children's Hospital
  Westerville, Ohio, United States

Description: The development of robust and reliable bioinformatic pipelines is seen throughout the field of molecular pathology to analyze NGS data and other large datasets. In the development of bioinformatic pipelines, considerations to quality and robustness of the pipeline must be considered including a way to identify the appropriate tools that should be utilized. This session will explore the development of bioinformatic pipelines within the ISO regulatory framework and approaches for benchmarking methods.

If this session topic is of interest to you, please consider looking at the following course on AMP EDucation (AMPED™ Online)

Title: Recommendations for the Use of In silico Approaches for Next Generation Sequencing Bioinformatic Pipeline Validation
Please Click Here to Learn More.

Presentations:

• 10:15 AM - 11:00 AM EST

  Development of Bioinformatic Tools - Best Practices for Validation
  

  Breakout Speaker: Matthew Lebo, PhD (he/him/his) – Mass General Brigham Personalized Medicine
• 11:00 AM - 11:45 AM EST

  Developing Robust Bioinformatics Approaches for Accredited Infectious Disease Genomics Services
  

  Breakout Speaker: Thomas R. Connor, PhD (he/him/his) – Cardiff University and Public Health Wales NHS Trust